iData Insights

FORUM Pharmaceuticals Inc. - Product Pipeline Review – 2015

Press Release   •   Dec 07, 2015 14:12 IST

FORUM Pharmaceuticals Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct s, FORUM Pharmaceuticals Inc. - Product Pipeline Review - 2015, provides an overview of the FORUM Pharmaceuticals Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of FORUM Pharmaceuticals Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of FORUM Pharmaceuticals Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of FORUM Pharmaceuticals Inc.s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the FORUM Pharmaceuticals Inc.s pipeline products Reasons to buy - Evaluate FORUM Pharmaceuticals Inc.s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of FORUM Pharmaceuticals Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the FORUM Pharmaceuticals Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of FORUM Pharmaceuticals Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of FORUM Pharmaceuticals Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of FORUM Pharmaceuticals Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues

Browse Complete Report with TOC @

To Get Sample Copy of Report visit @

Table of Contents

Table of Contents

2 List of Tables

4 List of Figures

4 FORUM Pharmaceuticals Inc. Snapshot

5 FORUM Pharmaceuticals Inc. Overview

5 Key Information 5 Key Facts

5 FORUM Pharmaceuticals Inc. Research and Development Overview

6 Key Therapeutic Areas 6 FORUM Pharmaceuticals Inc. Pipeline Review 8 Pipeline Products by Stage of Development

8 Pipeline Products Monotherapy

9 FORUM Pharmaceuticals Inc. Pipeline Products Glance

10 FORUM Pharmaceuticals Inc. Late Stage Pipeline Products

10 Phase III Products/Combination Treatment Modalities

10 FORUM Pharmaceuticals Inc. Clinical Stage Pipeline Products

11 Phase II Products/Combination Treatment Modalities

11 Phase I Products/Combination Treatment Modalities

12 FORUM Pharmaceuticals Inc. Early Stage Pipeline Products

13 Preclinical Products/Combination Treatment Modalities

13 FORUM Pharmaceuticals Inc. Drug Profiles

14 encenicline hydrochloride

14 Product Description

14 Mechanism of Action

14 R&D Progress

14 FRM-0334

17 Product Description

17 Mechanism of Action

17 R&D Progress

17 FRM-6308

19 Product Description

19 Mechanism of Action

19 R&D Progress

19 Small Molecules to Agonize Alpha7 Acetylcholine Receptor for Cognitive Impairment

20 Product Description

20 Mechanism of Action

20 R&D Progress

20 Small Molecules to Modulate Gamma Secretase for Alzheimer's Disease

21 Product Description 21 Mechanism of Action

21 R&D Progress

21 FORUM Pharmaceuticals Inc. Pipeline Analysis

22 FORUM Pharmaceuticals Inc. Pipeline Products by Target

22 FORUM Pharmaceuticals Inc. Pipeline Products by Route of Administration

23 FORUM Pharmaceuticals Inc. Pipeline Products by Molecule Type

24 FORUM Pharmaceuticals Inc. Pipeline Products by Mechanism of Action 25 FORUM Pharmaceuticals Inc. Recent Pipeline Updates

26 FORUM Pharmaceuticals Inc. Dormant Projects

30 FORUM Pharmaceuticals Inc. Locations And Subsidiaries

31 Head Office

31 Other Locations & Subsidiaries

31 Appendix

32 Methodology 32 Coverage

32 Secondary Research

32 Primary Research 32 Expert Panel Validation 32 Contact Us 32 Disclaimer 33

Read More @

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

Contact Us:
iData Insights

Tel: 1-866-237-2965


AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects.